TICKERNERD
Menu
CTEVCTEVHealthcare · Health Information Services

CTEV Stock Forecast: Claritev Corp. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$24
+6.96% on the day

The 6 Wall Street analysts covering Claritev Corp. hold a median 12-month price target of $38 — +54.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 38 of 100 as at 1 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$387.2M
Ticker Nerd rank
38 / 100
Median analyst target
$38
Analysts covering
6
Total return, dividends reinvested
1W
+11.3%
1M
−25.6%
YTD
−43.2%
1Y
−36.9%
From 52W high
−66.5%
From 52W low
+80.3%
$13
$73
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CTEV stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Claritev Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
38 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
85
Growth
85
Size
57
Quality
43
Revisions
39
Value
34
Issuance
31
Momentum
30
Volatility
12

Accruals (85): Reported profit is backed by cash, and the company is not expanding recklessly.

Volatility (12): The share price moves around a lot.

The rank is the raw material. Whether the rules would actually own Claritev Corp. — and when they’d sell — is the membership.

Wall Street

CTEV stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CTEV, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$20$30$40$50$60$70$80Oct 25Jan 26Apr 26Jul 26CTEVHigh $61Median $38Low $22

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says6 analysts
5 Buy1 Hold0 Sell
Low $22Median $38High $61

The green dot is the last close — the median target sits +54.4% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
21 July 2026Canaccord GenuityMaintainsBuy$32 → $37
29 May 2026Canaccord GenuityInitiatesBuy$32
29 May 2026Canaccord GenuityInitiatesBuy—
24 Apr 2026BarclaysInitiatesOverweight—
19 Mar 2026Wells FargoMaintainsEqual-Weight—
25 Feb 2026CitigroupMaintainsBuy—
24 Feb 2026GuggenheimMaintainsBuy—
24 Feb 2026Wells FargoMaintainsEqual-Weight—
9 Jan 2026CitigroupMaintainsBuy—
9 Jan 2026Wells FargoInitiatesEqual-Weight—
10 Nov 2025CitigroupMaintainsBuy—
22 Oct 2025CitigroupUpgradeBuy—
21 Oct 2025CitigroupUpgradeBuy—
15 Aug 2025Piper SandlerMaintainsOverweight—
29 May 2025Piper SandlerUpgradeOverweight—
10 Mar 2025Piper SandlerMaintainsNeutral—
10 Jan 2025CitigroupMaintainsNeutral—
23 Sept 2024CitigroupMaintainsNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

CTEV analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.6%
Analysts raising
0
Analysts cutting
0
Fundamentals

Claritev Corp. (CTEV) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−1.3×

Cheaper than 83% of US stocks

Price / sales
0.4×

Cheaper than 86% of US stocks

Price / book
−1.6×

Cheaper than 95% of US stocks

EV / EBITDA
9.6×

Cheaper than 40% of US stocks

Growth & margins
Revenue growth (YoY)
5.8%

Higher than 43% of US stocks

Earnings growth (YoY)
5.8%

Higher than 44% of US stocks

Gross margin
67.0%

Higher than 81% of US stocks

Operating margin
7.5%

Higher than 62% of US stocks

Net margin
−29.3%

Higher than 13% of US stocks

Returns & dividend
Return on equity
170.1%

Higher than 98% of US stocks

Return on assets
1.1%

Higher than 51% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

CTEV vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
CTEVClaritev Corp.$387.2M
38
SLPSimulations Plus, Inc.$366.9M
86
EVHEvolent Health, Inc.$345.0M
58
CARLCarlsmed, Inc.$342.3M
26
NRCNRC Health$439.7M
86
SOPHSOPHiA GENETICS SA$466.7M
46
WEAVWeave Communications, Inc.$503.8M
73
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CTEV appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest CTEV news & analysis

Claritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record Levels

Business Wire · 30 July 2026positive

According to newly released 2025 CMS data, Claritev handled more federal Independent Dispute Resolution (IDR) claims than any other non-payer participant, making it the leading independent IDR administrator among all non-payer entities.

Why it matters — CTEV watchers would care because this CMS data positions Claritev as the top independent IDR administrator in the federal No Surprises Act dispute resolution process, underscoring its market leadership in healthcare transparency and affordability.

Claritev™ and SAVVI Financial® Collaborate to Deliver the Next Generation of Healthcare Benefit Decision Support

PRNewsWire · 28 July 2026positive

Claritev and SAVVI Financial announced a collaboration to deliver a new solution combining claims-informed intelligence with AI-powered financial guidance to help employees make smarter benefits decisions.

Why it matters — This partnership expands Claritev's healthcare decision-support capabilities by integrating AI-powered financial guidance, potentially strengthening its product offering in the benefits market.

FAQ

Frequently asked questions about CTEV stock

What is the CTEV stock price forecast for 2026-2027?

The 6 Wall Street analysts covering Claritev Corp. have a median 12-month price target of $38, with estimates ranging from $22 to $61. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CTEV stock a buy right now?

Of the 6 analysts covering Claritev Corp., 5 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Claritev Corp. 38 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CTEV?

As at 1 Aug 2026, Claritev Corp. ranks 38 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (85 of 100).

Will CTEV stock go up?

No one can know that. What the data says: the median 12-month target from 6 analysts implies +54.4% from the last close, and Ticker Nerd's factor model ranks Claritev Corp. 38 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CTEV stock forecast for 2030?

No analyst covering Claritev Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CTEV are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $22 to $61 over the next 12 months.

How has CTEV stock performed over the past year?

Claritev Corp. returned -36.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Claritev Corp. do?

Claritev Corporation is a distinguished entity in the realm of advanced technological solutions, predominantly serving the information technology and data analytics sectors. Its primary function revolves around providing cutting-edge analytical tools and platforms that enable businesses to harness the power of data-driven insights.

What is the latest news on CTEV?

The most recent item we track (Business Wire, 30 July 2026): "Claritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record Levels". According to newly released 2025 CMS data, Claritev handled more federal Independent Dispute Resolution (IDR) claims than any other non-payer participant, making it the leading independent IDR administrator among all non-payer entities.

Company

About Claritev Corp.

Claritev Corporation is a distinguished entity in the realm of advanced technological solutions, predominantly serving the information technology and data analytics sectors. Its primary function revolves around providing cutting-edge analytical tools and platforms that enable businesses to harness the power of data-driven insights. Claritev Corporation is renowned for its innovative approach to big data integration, artificial intelligence, and cloud computing technologies, allowing companies across various industries such as finance, healthcare, and retail to enhance operational efficiency and strategic decision-making. The company is strategically significant in empowering enterprises to transform raw data into actionable intelligence, thereby helping them understand market trends and customer behavior with greater accuracy. Moreover, Claritev Corporation's relentless commitment to research and development places it at the forefront of technological advancements, contributing to its pivotal role in shaping the future of digital transformation. Claritev's solutions not only cater to large corporations but also to growing startups, enabling a diverse range of clients to achieve higher productivity and a competitive edge in the rapidly evolving market landscape.

CEO Mr. Travis S. Dalton · 3,000 employees · United States · https://www.claritev.com